- 13 WAYS TO KNOW IF THE GOVERNMENT IS READING YOUR EMAILPosted 9 hours ago
- 13 Ways To Know If The Government Is Reading Your EmailPosted 15 hours ago
- Video: Piers Morgan Says Obama is Borderline Tyrannical: ‘Now I See U.S. Government Tyranny’Posted 4 days ago
- FAMILIES OF DECEASED SEAL TEAM 6 MEMBERS ARE MAKING SERIOUS ALLEGATIONS AGAINST THE GOVERNMENTPosted 15 days ago
- European Commission to Criminalize Nearly all Seeds and Plants not Registered with GovernmentPosted 16 days ago
- After the Tragedy in Boston, More Government Surveillance is Not the AnswerPosted 17 days ago
- Video: Obama To Ohio State Grads-Reject Voices That Warn About Government TyrannyPosted 17 days ago
- AMERICANS FEAR GOVERNMENT MORE THAN TERRORPosted 24 days ago
- The Art of Catching Government False Flags in Real TimePosted 25 days ago
- SECRET GOVERNMENT DOCUMENTS REVEAL VACCINES TO BE A TOTAL HOAXPosted 30 days ago
Yummy! Digestible Microchips Embedded in Drugs
Nature
Digestible microchips embedded in drugs may soon tell doctors whether a patient is taking their medications as prescribed. These sensorsare the first ingestible devices approved by the US Food and Drug Administration (FDA). To some, they signify the beginning of an era in digital medicine.
“About half of all people don’t take medications like they’re supposed to,” says Eric Topol, director of the Scripps Translational Science Institute in La Jolla,California. “This device could be a solution to that problem, so that doctors can know when to rev up a patient’s medication adherence.” Topol is not affiliated with the company that manufactures the device, Proteus Digital Health in Redwood City,California, but he embraces the sensor’s futuristic appeal, saying, “It’s like big brother watching you take your medicine.”
The sand-particle sized sensor consists of a minute silicon chip containing trace amounts of magnesium and copper. When swallowed, it generates a slight voltage in response to digestive juices, which conveys a signal to the surface of a person’s skin where a patch then relays the information to a mobile phone belonging to a healthcare-provider.
Currently, the FDA, and the analogous regulatory agency in Europe have only approved the device based on studies showing its safety and efficacy when implanted in placebo pills. But Proteus hopes to have the device approved within other drugs in the near future. Medicines that must be taken for years, such as those for drug resistant tuberculosis, diabetes, and for the elderly with chronic diseases, are top candidates, says George Savage, co-founder and chief medical officer at the company.





